Maven Securities’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.76M Sell
15,900
-22,500
-59% -$4.61M 0.05% 237
2025
Q4
$9.84M Sell
38,400
-18,200
-32% -$4.77M 0.22% 111
2025
Q3
$14.7M Buy
56,600
+42,100
+290% +$11.1M 0.36% 64
2025
Q2
$3.54M Buy
14,500
+500
+4% +$125K 0.08% 218
2025
Q1
$3.7M Buy
14,000
+13,100
+1,456% +$3.54M 0.11% 172
2024
Q4
$228K Sell
900
-7,900
-90% -$2.12M 0.01% 754
2024
Q3
$2.79M Sell
8,800
-6,400
-42% -$2.28M 0.05% 284
2024
Q2
$5.68M Buy
+15,200
New +$5.13M 0.13% 169
2024
Q1
Sell
-18,900
Closed -$8.65M 644
2023
Q4
$8.65M Buy
18,900
+8,100
+75% +$3.99M 0.18% 94
2023
Q3
$5.25M Buy
10,800
+9,700
+882% +$4.56M 0.06% 182
2023
Q2
$492K Buy
1,100
+600
+120% +$302K 0.01% 622
2023
Q1
$243K Sell
500
-1,100
-69% -$544K 0.01% 843
2022
Q4
$820K Buy
1,600
+800
+100% +$420K 0.02% 464
2022
Q3
$388K Buy
800
+300
+60% +$146K 0.01% 868
2022
Q2
$234K Buy
500
+200
+67% +$89K 0.01% 811
2022
Q1
$131K Buy
+300
New +$125K ﹤0.01% 839

Other funds holding HUM

Maven Securities's HUM Position: Q3 2025 in Review

Maven Securities sold out of Humana (HUM) in Q3 2025, closing a stake of 2,926 shares — an estimated $769K sold.

Maven Securities first reported a position in HUM in Q4 2020 and held it in 7 quarters. The position peaked at $715K in Q2 2025. 890 funds tracked by Wall St. Rank hold HUM as of Q3 2025.

  • Maven Securities reported no remaining Humana position as of Q3 2025 after selling out during the quarter.
  • Maven Securities sold 2,926 Humana shares in Q3 2025, an estimated $769K.
  • Maven Securities first reported a position in Humana in Q4 2020 and held it in 7 quarters.
  • Maven Securities's Humana position peaked at $715K in Q2 2025.
  • 890 funds tracked by Wall St. Rank held Humana as of Q3 2025.

Based on Maven Securities's 13F filing for Q3 2025, filed 20 Nov 2025.